In contrast, finding an optimal balance between maximal resection and preservation of the quality of daily life is of utmost importance for IDH-mutant (IDHmt) World Health Organization (WHO) grade 2 and 3 gliomas (lower-grade gliomas: LrGGs), as these present a more favorable prognosis1–5. This evidence concerns the gene IDH2 and glioma.